Friday, July 10, 2026

pharma · Weight management · Short Bowel Syndrome

Zealand Pharma

Zealand Pharma A/S is a pharma organization headquartered in EU. Primary therapeutic focus areas include Weight management, Short Bowel Syndrome, Children with congenital hyperinsulinism, Critically Ill, Mechanically Ven

Sydmarken 11, Søborg (Copenhagen), 2860, DK HQ
1998 Founded
596 Employees
EMA registrant Type
Company details
Status
Public
HQ
Sydmarken 11, Søborg (Copenhagen), 2860, DK
Founded
1998
Employees
596
Programs
18
Drugs
20
Patents
0
Clinical program

Ropivacaine

Unknown · small molecule · Pain, Postoperative

Ropivacaine for Pain, Postoperative is a Unknown program (small_molecule) at Zealand Pharma A/S with 1 ClinicalTrials.gov record(s).

← All Zealand Pharma A/S projects Unknown small molecule terminated

Internal code COLVHR

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Zealand Pharma A/S
Phase
Unknown
Modality
small_molecule
Indication
Pain, Postoperative
Status
terminated
Trials
1